Inhaled Nitric Oxide in Acute Severe Pulmonary Hypertension and Severe Acute Respiratory Distress Syndrome Secondary to COVID-19 Pneumonia: A Case Report

25 October 2022: Articles

Challenging differential diagnosis, Unusual setting of medical care, Rare disease

Marc Vives ^A* , Iñaki Gascó ^B , Guillem Pla ^B , Jorge Luis Maciel ^B , Ana Ricart Hernandez ^B , Kevin Regí Roman ^B , Fina Parramon ^B

DOI: 10.12659/AJCR.937147

Am J Case Rep 2022; 23:e937147

Table 3. Laboratory analysis after inhaled nitric oxide treatment period.

	D11	D12	D13	D14	D15
PaO2/FiO2 (mmHg)	200	205	212	215	210
Ventilatory mode	PS	PS	PS	PS	PS
Leukocytes (×10/L)	16	16.8	26	19	17
CRP (mg/L)	6.2	10.7	13.7	16.9	7.4
Hb (g/dL)	8.9	9.1	7.9	7.8	7.8
Platelets (×10/L)	598	583	430	399	403
FBG (mg/dL)	630	878	880	992	862
PCT (ng/mL)	0.07
CRP – C-reactive protein; D11 – day 11; D12 – day 12; D13 – day 13; D14 – day 14; D15 – day 15; D16 – day 16; D17 – day 17; D18 – day 18; D19 – day 19; D20 – day 20; D21 – day 21; FBG – fibrinogen; Hb – hemoglobin; HFNC – high flow nasal cannula; PCT – procalcitonin; PS – pressure support; trachea – tracheostomy.
	D16	D17	D18	D19	D20	D21
PaO2/FiO2 (mmHg)	208	220	225	300	330	270
Ventilatory mode	PS	PS	PS	HFNC by tracheo	HFNC by tracheo	Mask
Leukocytes (×10/L)	17	13.8	12	13	12	10
CRP (mg/L)	5.2	3.3	1.88	2.98	2.12	1
Hb (g/dL)	7.3	8	8.4	8.8	8.3	8.7
Platelets (×10/L)	383	353	376	447	351	301
FBG (mg/dL)	780	710	687	667	603	546
PCT (ng/mL)
CRP – C-reactive protein; D11 – day 11; D12 – day 12; D13 – day 13; D14 – day 14; D15 – day 15; D16 – day 16; D17 – day 17; D18 – day 18; D19 – day 19; D20 – day 20; D21 – day 21; FBG – fibrinogen; Hb – hemoglobin; HFNC – high flow nasal cannula; PCT – procalcitonin; PS – pressure support; trachea – tracheostomy.